11 October
12 October
11 October
13.50-14.00 | OPENING REMARKS OF EHOC 2023 | |||
16.05-16.35 | POSTER WALK WITH COFFEE BREAK | Chairs: Meryem Albayrak, Serap Karaman | ||
A Comparative Study of Conventional Blood Culture Method vs Sepsis Qpcr Mx-30 Panel in Patients With Pediatric Leukemia |
Fatma Burçin Kurtipek |
|||
Is There an Association Between Pulmonary Embolism and the Use of Peg-Asparaginase in Children With Leukemia? |
Emine Yılmaz Orulluoğlu |
|||
Evaluation of Menstruation Related Quality of Life in Adolescents With Abnormal Uterine Bleeding |
Fatma Burçin Kurtipek |
|||
Evaluation of Glucose-6-Phosphate Dehydrogenase Deficiency in Patients With Sickle Cell Anemia |
Şule Çalışkan Kamış |
12 October
HALLS |
PEDIATRIC HEMATOLOGY PROGRAM |
|||
08.15-08.45 | ORAL COMMUNICATION SESSIONS (PEDIATRIC HEMATOLOGY) | Chairs : Meryem Albayrak , Serap Karaman | ||
08.15-08.25 |
Molecular Characteristics and Treatment Response to Cog All Protocol in Children; a 16-Year Single-Center Study |
Bengisu Güner Yılmaz(Virtual) |
|
|
08.25-08.35 |
Assessment of Vitamin B12 and Homocysteine Levels in Pregnant Women Admitted For Delivery and Cord Blood Samples of Their Newborn Babies: A Multicenter Study |
Dildar Bahar Genç |
|
|
08.35-08.45 |
Bk-Virus Infections In Pediatric Leukemia Patients During Leukemia Treatment |
Dilek Kaçar |
|
|
09.00-10.00 |
ADULT & PEDIATRIC ONCOHEMATOLOGY JOINT (BMT VS CAR T CELL) |
CHAIRS: Khalid Halahleh – Oral Nevruz |
||
09.00-09.10 |
State of the Art |
Arnon Nagler(Virtual) |
||
09.10-09.30 |
Is Hematopoietic Stem Cell Transplantation Necessary to Consolidate Hematological Remission After CAR-T Therapy? |
Francesco Saglio |
||
09.30-09.50 |
Post CAR-T: To Transplant, or Not To Transplant, That’s The Question! |
Koray Yalçın |
||
09.50-10.00 |
Future Perspectives |
Fatma Visal Okur |
||
10.00-11.00 |
ADULT & PEDIATRIC HEMATOLOGY ON HEMOGLOBINOPATHIES JOINT SESSION |
CHAIRS: Salam Al-Kindi – Fahri Şahin |
||
10.00-10.10 |
State of the Art |
Maria Capellini(Virtual) |
||
10.10-10.30 |
A Patient Case on Non-Transfusion Dependent Thalassemia |
Ali Taher(Virtual) |
||
10.30-10.50 |
Patient 2 - Presentation and Discussion |
Anıl Tombak |
||
10.50-11.00 |
Future Perspectives |
Salam Al-Kindi |
||
11.00-11.30 | COFFEE BREAK | |||
11.30-12.50 |
SESSION 2 - Chronic Myeloid Leukemia |
CHAIRS: Adalet Meral Güneş, Zeynep Karakaş |
||
11.30-11.50 |
Diagnosis |
Adalet Meral Güneş |
||
11.50-12.10 |
Treatment Options and Follow-up |
Özlem Tüfekçi Gürocak |
||
12.10-12.30 |
Therapeutic Challenges and Bone Marrow Transplantation |
Talia İleri |
||
12.30-12.50 |
Discussion |
Adalet Meral Güneş |
||
12.50-13.20 | ORAL COMMUNICATION SESSIONS (PEDIATRIC HEMATOLOGY) | Chairs: Meryem Albayrak , Serap Karaman | ||
12.50-13.00 |
The Coexistence of Novel Mutations of FX, Dimethylglycine Dehydrogenase Genes With Familial Episodic Pain Syndrome: A Case Report |
Hatice Mine Çakmak |
||
13.00-13.10 |
Investigation of Salivary Mir-9 And Serum Cip2a Levels in Fanconi Anemia Patients at High Risk Of Developing Oral Squamous Cell Carcinoma |
Zişan Asal Kılıç |
||
13.10-13.20 |
Busulfan-Cyclophosphamide or Treosulfan-Fludarabine-Thiotepa-Based Myeloablative Conditioning For Children With Thalassemia Major, Single Centre Experience |
Nihan Bayram |
||
13.20-14.20 | LUNCH BREAK | |||
14.20-15.50 |
SESSION 3 - Acute Myeloid Leukemia |
CHAIRS: Hale Ören, Neşe Yaralı |
||
14.20-14.40 |
Acute Myeloid Leukemia: Diagnosis and Risk Strafication |
Nihal Karadaş |
||
14.40-15.00 |
Acute Myeloid Leukemia: Treatment Approaches and Emphasizing Role of Targeted Therapies |
Emel Özyürek |
||
15.00-15.20 |
Acute Promyelocytic Leukemia: Risk Stratification and New Treatment Modalities |
Suar Çakı Kılıç |
||
15.20-15.50 |
Discussion |
Hale Ören |
||
15.50-16.20 | ORAL COMMUNICATION SESSIONS (PEDIATRIC HEMATOLOGY) | Chairs : Meryem Albayrak , Serap Karaman | ||
15.50-16.00 |
Effect of Graft Versus Host Dısease Prophylaxis on The Leukemia Free Survival In Pediatric Patients Who Hematopoetic Stem Cell Transplanted For Leukemia |
Özge Aylin Boran(Virtual) |
||
16.00-16.10 |
The Significance of Next-Generation Sequencing In Non-Immune Hemolytic Anemias Among Normochromic-Normocytic Anemias |
Hatice Mine Çakmak |
||
16.10-16.20 |
A Next-Generation Sequencing Test For Congenital Neutrıpenia in Pediatric Patient |
Ayça Koca Yozgat |
||
16.20-17.45 |
SESSION 4 - Pediatric Hemophagocytic Lymphohistiocytosis |
CHAIRS: Nazan Sarper, Tiraje Celkan |
||
16.20-16.35 |
Terminology and Diagnosis |
Ebru Yılmaz Keskin |
||
16.35-16.50 |
Genetic Causes of HLH |
Turan Bayhan |
||
16.50-17.05 |
Seconday Causes of HLH |
Yeşim Oymak |
||
17.05-17.20 |
Current Treatment of Primary and Secondary HLH |
Selin Aytaç Eyüpoğlu |
||
17.20-17.45 |
Discussion |
Zühre Kaya |
||
17.45-18.15 | POSTER WALK WITH COFFEE BREAK | Chairs: Meryem Albayrak , Serap Karaman | ||
Evaluation of Thrombosis Risk Factors and Prognosıs in Childhood Thrombosis |
Mehmet Fatih Alpkıray |
|||
A Pediatric Chronic Eosinophilic Leukemia Case Succesfully Treated With Stem Cell Transplantation After Transformation to Acute Lymphoblastic |
Hasan Fatih Çakmaklı |
|||
Sleep Qualıty In Patients With Β-Thalassaemia Major |
Funda Erkasar |
|||
Viral Infections In Pediatric Heamtopoietic Stem Cell Transplant Patients |
İrem Bozkurt |
|||
18.15-19.30 |
SESSION 5 - Hemophilia |
CHAIRS: Ayşegül Ünüvar, Namık Yaşar Özbek |
||
18.15-18.35 |
Extended Half Life Coagulation Factors |
Canan Albayrak |
||
18.35-18.55 |
New Treatment Modalities in Hemophilia |
Başak Koç |
||
18.55-19.15 |
Gene Therapy in Hemophilia |
Ayşegül Ünüvar |
||
19.15-19.30 |
Discussion |
Alphan Küpesiz |